Lung Cancer Screening and Prevention Act of 2023

Bill 118 hr 6693, also known as the Lung Cancer Screening and Prevention Act of 2023, aims to address the growing issue of lung cancer in the United States. The bill focuses on increasing access to screening and prevention measures for individuals at high risk of developing lung cancer.

One key provision of the bill is the establishment of a national screening program for individuals who are considered high risk for lung cancer. This program would provide low-dose computed tomography (CT) scans for eligible individuals, such as current or former smokers, in order to detect lung cancer at an early stage when it is more treatable.

Additionally, the bill includes provisions for increasing public awareness about the risks of lung cancer and the importance of early detection. This includes funding for public education campaigns and outreach programs to encourage individuals to undergo screening and adopt healthy behaviors that can reduce their risk of developing lung cancer. Furthermore, the bill allocates funding for research into new screening technologies and prevention strategies for lung cancer. This research will help to improve the effectiveness of screening programs and identify new ways to prevent lung cancer from developing in the first place. Overall, the Lung Cancer Screening and Prevention Act of 2023 aims to reduce the burden of lung cancer in the United States by increasing access to screening and prevention measures, raising public awareness about the disease, and supporting research into new ways to detect and prevent lung cancer.